Elle Kolkin

Appearances

MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
Date
May 8, 2023
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Presenter
Lizeth Cifuentes
Speakers
Timothy O'Connor
Wissam Ghusn
Alejandro Campos
Alison Mcrae
Elle Kolkin
Maria Hurtado
Michael Camilleri
Mayo Clinic College of Medicine
Andres Acosta
Mayo Foundation for Medical Education and Research
PERFORMANCE OF A MACHINE-LEARNING GENE RISK SCORE BIOMARKER ON PREDICTING RESPONSE TO SEMAGLUTIDE: A PROSPECTIVELY FOLLOWED MULTI-CENTER BIOBANK AND OUTCOMES REGISTRY
Date
May 20, 2024
BACKGROUND: Our phenotype-guided approach to antiobesity medications is associated with greater weight loss compared to the obesity medicine standard of care…
Presenter
Sima Fansa
Speakers
Elif Tama
Diego Anazco
Lizeth Cifuentes
Wissam Ghusn
Khushboo Gala
Elle Kolkin
Timothy O'Connor
Andres Acosta
Mayo Foundation for Medical Education and Research
Maria Hurtado